Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mayne Pharma
Marketing
FDA accuses Mayne of giving misleading impression of drug safety
The FDA alleged Mayne minimized the risks associated with Nextstellis and misrepresented how the drug compares to rival contraceptives.
Nick Paul Taylor
May 13, 2025 9:30am
Cosette snaps up Mayne Pharma for $430M
Feb 21, 2025 11:20am
Teva recalls fentanyl buccal tablets produced for Mayne Pharma
May 1, 2023 2:32pm
Dr. Reddy's takes over Mayne's US generics in $105M deal
Feb 27, 2023 11:43am
TherapeuticsMD to slash its entire workforce of 212 people
Dec 9, 2022 8:15am
Catalent snaps up CDMO Metrics and its NC plant for $475M
Aug 10, 2022 10:15am
